Receptor tyrosine-protein kinase erbB-2 (654-662)

Receptor tyrosine-protein kinase erbB-2 (654-662) is a synthetic peptide fragment corresponding to amino acids 654 through 662 of the human HER2/neu (erbB-2) protein. As a segment of a well-characterized receptor tyrosine kinase, this peptide is highly relevant in cellular signaling research, particularly in studies related to oncogenic pathways and receptor-mediated signal transduction. Its defined sequence and origin from a biologically significant protein make it a valuable reagent for dissecting molecular interactions, phosphorylation events, and immunological recognition associated with HER2/neu. Researchers utilize this peptide to probe the functional domains of erbB-2, investigate post-translational modifications, and develop tools for mapping protein-protein interactions within critical signaling cascades.

Epitope mapping: The 654-662 peptide fragment is widely employed in epitope mapping studies to identify antibody binding sites on the HER2/neu receptor. By providing a precise linear sequence from the intracellular domain of erbB-2, it enables researchers to characterize monoclonal and polyclonal antibody specificity, facilitating the development and validation of immunoassays. Such mapping is essential for understanding immune recognition and for designing antibodies with improved selectivity for research and diagnostic applications.

Kinase substrate assays: As a representative sequence from the cytoplasmic domain of erbB-2, this peptide serves as an effective substrate in in vitro kinase assays. Researchers use it to assess the phosphorylation activity of recombinant or purified tyrosine kinases, including HER2/neu and related enzymes. By monitoring phosphorylation events on this fragment, scientists can evaluate kinase activity, screen for inhibitors, and investigate the molecular mechanisms underlying signal transduction in cancer and other proliferative disorders.

Protein-protein interaction studies: The erbB-2 (654-662) peptide is utilized in biochemical assays designed to elucidate specific binding interactions between the HER2/neu receptor and intracellular adaptor proteins or regulatory molecules. Its defined sequence allows for the identification of docking motifs, SH2 domain recognition, and other critical contacts that mediate downstream signaling. Such studies provide valuable insights into the assembly and regulation of multi-protein complexes involved in cellular growth and differentiation.

Immunogenicity research: The defined linear sequence of this peptide makes it a useful tool for evaluating T cell responses and antigen processing in immunological studies. By incorporating the fragment into antigen presentation assays or ex vivo stimulation protocols, researchers can assess the immunogenic potential of specific HER2/neu epitopes. This application supports the design of immunological reagents and the investigation of immune surveillance mechanisms in oncogenic contexts.

Analytical standard in proteomics: The erbB-2 (654-662) peptide can be applied as a reference standard or calibration peptide in mass spectrometry-based proteomic workflows. Its well-characterized sequence and physicochemical properties make it suitable for optimizing peptide identification parameters, quantifying HER2/neu-derived fragments, and validating analytical methodologies. The use of such standards enhances the reliability and reproducibility of peptide-based detection techniques in protein characterization studies.

1. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

2. Cationic cell-penetrating peptides are potent furin inhibitors

3. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

5. The spatiotemporal control of signalling and trafficking of the GLP-1R